Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benaglutide vs Liraglutide for Weight and Gut Microbiota in Obesity
NCT03986008Phase 3Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of beinaglutide in obesity, sponsored by Xiangya Hospital, Central South University. Status: unknown.
02
Drugs
beinaglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03986008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03986008.